The results of study, published in Nature Biotech, described the implantation of a specially engineered patch of retinal pigment epithelium cells derived from stem cells to treat people with sudden severe sight loss from wet AMD. It's the first description of a complete engineered tissue that has been successfully used in this way. The researchers hope that the treatment will also help treat dry AMD in the future.